Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-κB, osteoprotegerin, or sequestosome-1 gene defects

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1897-1901

  Simsek, Suat ^a   Basoski, Natalja M ^a   Bravenboer, Nathalie ^a   Zhang, Xiafang ^b   Mumm, Steven ^b,c   Whyte, Michael P ^b,c   Netelenbos, J Coen ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; HYDROXYPROLINE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN; RADIOISOTOPE; SEQUESTOSOME 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE MARROW BIOPSY; BONE PAIN; BONE SCINTISCANNING; BONE TURNOVER; CASE REPORT; ERYTHROCYTE SEDIMENTATION RATE; EXON; FEMALE; FINGER; FLUORESCENCE MICROSCOPY; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; HUMAN TISSUE; HYDROXYPROLINE URINE LEVEL; HYPEROSTOSIS; HYPERPHOSPHATASEMIA; ILIAC CREST; LUNG DISEASE; MORPHOMETRICS; OSTEOLYSIS; PAGET BONE DISEASE; PAIN; PERIOSTITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOLOGY; RIGIDITY; BLOOD; BONE; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; SCINTISCANNING; SYNDROME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; FEMALE; FINGERS; HUMANS; INFLAMMATION; OSTEOPROTEGERIN; PAIN; PERIOSTITIS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SYNDROME;

EID: 34249860937     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0479     Document Type: Article

References (36)

1. Cole DEC, Whyte MP 1996 Hyperphosphatasia syndromes. In: Cohen Jr MM, Baum BJ, eds. Studies in stomatology and craniofacial biology. Amsterdam: IOS Press; 245-272
2. Whyte MP, Mumm S 2004 Heritable disorders of the RANKL/OPG/RANK signaling pathway. J Musculoskelet Neuronal Interact 4:254-267
3. McKusick VA 2006 Online Mendelian inheritance in man, OMIM. Baltimore, MD: McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University, and Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine. www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=174810
4. Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45-48
5. Whyte MP, Reinus WR, Podgornik MN, Mills BG 2002 Familial expansile osteolysis (excessive RANK effect) in a 5-generation American kindred. Medicine (Baltimore) 81:101-121
6. Palenzuela L, Vives-Bauza C, Fernández-Cadenas I, Meseguer A, Font N, Sarret E, Schwartz S, Andreu AL 2002 Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J Med Genet 39:e67
7. Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ 2003 Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res 18:376-380
8. Osterberg PH, Wallace RG, Adams DA, Crone RS, Dickson GR, Kanis JA, Mollan RA, Nevin NC, Sloan J, Toner PG 1988 Familial expansile osteolysis. A new dysplasia. J Bone Joint Surg Br 70:255-260
9. Wallace RG, Barr RJ, Osterberg PH, Mollan RA 1989 Familial expansile osteolysis. Clin Orthop Relat Res 248:265-277
10. Crone MD, Wallace RG 1990 The radiographic features of familial expansile osteolysis. Skeletal Radiol 19:245-250
11. Esselman GH, Goebel JA, Wippold 2nd FJ 1996 Conductive hearing loss caused by hereditary incus necrosis: a study of familial expansile osteolysis. Otolaryngol Head Neck Surg 114:639-641
12. Mitchell CA, Kennedy JG, Wallace RG 1990 Dental abnormalities associated with familial expansile osteolysis: a clinical and radiographic study. Oral Surg Oral Med Oral Pathol 70:301-307
13. Mitchell CA, Kennedy JG, Owens PD 1990 Dental histology in familial expansile osteolysis. J Oral Pathol Med 19:65-70
14. Nakatsuka K, Nishizawa Y, Ralston SH 2003 Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 18:1381-1385
15. Whyte MP, Mills BG, Reinus WR, Podgornik MN, Roodman GD, Gannon FH, Eddy MC, McAlister WH 2000 Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res 15:2330-2344
16. Whyte MP, Hughes AE 2002 Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 17:26-29
17. Golob DS, McAlister WH, Mills BG, Fedde KN, Reinus WR, Teitelbaum SL, Beeki S, Whyte MP 1996 Juvenile Paget disease: life-long features of a mildly affected young woman. J Bone Miner Res 11:132-142
18. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S 2002 Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 347:175-184
19. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie C, Cornish J 2002 A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11:2119-2127
20. Chong B, Hegde M, Fawkner M, Simonet S, Cassinelli H, Coker M, Kanis J, Seidel J, Tau C, Tuysuz B, Yuksel B, Love D; International Hyperphosphatasia Collaborative Group 2003 Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J Bone Miner Res 18:2095-2104
21. Mumm S, Banze S, Pettifor J, Tau C, Schmitt K, Ahmed A, Whyte MP 2003 Juvenile Paget's disease: molecular analysis of TNFRSF11B encoding osteoprotegerin indicates homozygous deactivating mutations from consanguinity as the predominant etiology. J Bone Miner Res 18(Suppl 2):S388 (Abstract)
22. Whyte MP 2006 Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling. Ann NY Acad Sci 1068:143-164
23. Kanis J 1998 Pathophysiology and treatment of Paget's disease of bone. 2nd ed. London: Martin Dunitz
24. Laurin N, Brown JP, Morissette J, Raymond V 2002 Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582-1588
25. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH 2002 Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11:2735-2739
26. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
27. Layfield R, Hocking LJ 2004 SQSTM1 and Paget's disease of bone. Calcif Tissue Int 75:347-357
28. Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W 2001 Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28:104-107
29. Von Bamberger E 1889 Veränderungen der Röhrenknochen bei Bronchiektasie. Wiener klinische Wochenschrift 2:226
30. Marie P 1890 De l'osteo-arthropathie hypertrophiante pneumique. Rev Med 10:1
31. Coury C 1960 Hippocration fingers and hypertrophic osteoarthropathy. A study of 350 cases. Br J Dis Chest 54:202-209
32. Jajic Z, Jajic I, Nemcic T 2001 Primary hypertrophic osteoarthropathy: clinical, radiologic, and scintigraphic characteristics. Arch Med Res 32:136-142
33. Vandemergel X, Blocklet D, Decaux G 2004 Periostitis and hypertrophic osteoarthropathy: etiologies and bone scan patterns in 115 cases. Eur J Intern Med 15:375-380
34. Herneth AM, Breitenseher MJ, Funovics M, Nehrer S, Huber WD, Imhof H 1999 Quiz case 12. Marie-Bamberger syndrome (MBS) (hypertrophic osteoarthropathy (HOA) secondary to ulcerative colitis (UC). Eur J Radiol 32:124-128
35. Melhem RE, Najjar SS, Khachadurian AK 1970 Cortical hyperostosis with hyperphosphatemia: a new syndrome? J Pediatr 77:986-990
36. Mikati MA, Melhem RE, Najjar SS 1981 The syndrome of hyperostosis and hyperphosphatemia. J Pediatr 99:900-904